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Abstract
Objective. Pain prevalence data for patients at vari-
ous stages after stroke.
Design. Repeated cross-sectional, observational
epidemiological study.
Setting. Hospital-based multicenter study.
Subjects. Four hundred forty-three prospectively
enrolled stroke survivors.
Methods. All patientsunderwentbedsideclinical exami-
nation. The different types of post-stroke pain (central
post-stroke pain, musculoskeletal pains, shoulder pain,
spasticity-related pain, and headache) were diag-
nosed with widely accepted criteria during the acute,
subacute, and chronic stroke stages. Differences
among the three stageswere analyzedwith v2-tests.
Results. The mean overall prevalence of pain was
29.56% (14.06% in the acute, 42.73% in the suba-
cute, and 31.90% in the chronic post-stroke stage).
Time course differed significantly according to the
various pain types (P< 0.001). The prevalence of
musculoskeletal and shoulder pain was higher in
the subacute and chronic than in the acute stages
after stroke; the prevalence of spasticity-related
pain peaked in the chronic stage. Conversely, head-
ache manifested in the acute post-stroke stage. The
prevalence of central post-stroke pain was higher in
the subacute and chronic than in the acute post-
stroke stage. Fewer than 25% of the patients with
central post-stroke pain received drug treatment.
Conclusions. Pain after stroke is more frequent in
the subacute and chronic phase than in the acute
phase, but it is still largely undertreated.
Key Words. Stroke; Central Post-Stroke Pain;
Hemiplegic Shoulder Pain; Spasticity
Introduction
Pain is a common event in stroke survivors. Post-stroke
pain manifests in various ways including neuropathic
pain, namely central post-stroke pain (CPSP), nociceptive
pains (musculoskeletal pains, shoulder pain, spasticity-
related pain) and headache [1]. The estimated prevalence
rates range from 10% to 45.8% for post-stroke pain and
from 1% to 12% for CPSP [2,3]. This variability reflects
the different methodological approaches. Most studies
are based on retrospective data, and neglected to use
clinical examination or widely agreed criteria for distin-
guishing the different types of pain, or the recently pro-
posed criteria for diagnosing neuropathic pain [1,4,5].
Although clinicians commonly believe that headache
has an early onset whereas some post-stroke pains
(including CPSP and spasticity-related pain) have a
delayed onset, no study has directly investigated the
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time course of the various post-stroke pains. Having
more information on these events might improve the
clinical management of this complication that adversely
affects stroke patients’ quality of life.
This prospective, observational, repeated cross-
sectional, hospital-based, multicenter study was
designed to seek more reliable information on the prev-
alence and time course of the various post-stroke pains.
All patients enrolled underwent bedside clinical examina-
tion, and using widely accepted criteria we diagnosed
the different types of pain during the acute, subacute,
and chronic stages after stroke.
Methods
All patients consecutively admitted to the stroke units
and stroke rehabilitation divisions (both in the ward and
in the outpatient service) at eight Italian hospitals
between January 2010 and July 2012 were considered
eligible for the study (Figure 1). The study was con-
ducted in accordance with the Helsinki Declaration, and
informed consent was obtained before the examination.
The study was approved by the Institutional Review
Boards at the participating hospitals.
Inclusion criteria were a stroke diagnosis (defined as
a sudden, non-convulsive, focal neurological deficit
persisting for>24 hours [6]), age over 18 years, and
patient’s consent to a free participation to the study.
The diagnosis of stroke was based on clinical history,
clinical examination, and neuroradiological findings.
Patients were distinguished according to onset as hav-
ing acute (within 14 days after the event), subacute
(from day 15 to day 90), or chronic stroke (more than
90 days after the event). Exclusion criteria were as fol-
lows: negative neuroimaging findings, previous cere-
brovascular accidents, subarachnoid hemorrhage,
presence of coma or language disorder with severe
comprehension deficit (Token test, cut-off score of 29),
history of severe depression before stroke (needing
prolonged antidepressant treatment and/or admission
to a psychiatric ward), other chronic severe disabling
diseases (including severe Parkinson’s disease, poly-
neuropathy, severe cardiac, liver, or renal failure, can-
cer, and limb amputation). We also excluded patients
who complained of chronic pain before the stroke,
defined as any persistent or recurrent pain experienced
within the past 3 months and needing prolonged/
chronic analgesic medication. Antithrombotic stroke
therapy was not considered a reason to exclude
patients.
After enrolment all patients underwent a detailed neuro-
logical examination, using bedside tools and focused
assessment of sensory disturbances. Touch was
Figure 1 Study flow-chart.
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investigated with a piece of cotton wool, vibration with a
tuning fork (128 Hz), pinprick sensation with a wooden
cocktail stick, and thermal sensation with test tubes
containing warm and cold water. Patients were exam-
ined for negative (tactile, pinprick, and thermal hypoes-
thesia), and positive symptoms (constant pain,
paroxysmal pain, allodynia, and pinprick hyperalgesia).
The presence and severity of negative symptoms were
assessed by comparing the affected side with the mirror
image on the normal side. Using a structured interview
we collected demographic data and information on the
type and side of stroke, onset interval, severity of neuro-
logical impairment (with the National Institutes of Health
Stroke Scale [NIHSS]) and disability (with the Barthel
Index), comorbidities and concomitant treatment, and
pain at the time of examination.
CPSP was diagnosed according to the grading system
for the diagnosis of neuropathic pain [1,4,5]. Patients
were diagnosed as suffering from definite neuropathic
pain when examination excluded other likely causes of
pain, pain had a plausible neuroanatomical distribution,
a diagnosis of stroke, a plausible neuroanatomical distri-
bution confirmed by clinical findings, a DN4 question-
naire score of4 [7,8], and a compatible vascular lesion
on imaging. To assess the different symptoms and
severity of neuropathic pain we used the Italian version
of the Neuropathic Pain Symptom Inventory (NPSI), a
self-administered questionnaire consisting of 12 items
related to the different symptoms. Ten items assess the
intensity of pain by a 0–10 numerical scale (0¼no sen-
sation, 10¼worst possible pain) and two items assess
the frequency of pain [9,10]. Each NPSI subscore was
calculated.
We diagnosed nociceptive pains by clinical history and
examination and distinguished musculoskeletal pains
(including low back pain and joint pains), shoulder pain,
and spasticity-related pain. Musculoskeletal and
shoulder pains were diagnosed using combined inter-
view, physical examination, and diagnostic tests as
appropriate [11]. We diagnosed spasticity-related pain
when pain involved spasticity-affected limbs (spasticity
was defined as1 at any one of the major joints in the
arms and legs, using the 0–5 range on the Modified
Ashworth Scale). The diagnosis of stroke-related head-
ache adhered to the International Headache
Classification (headache attributed to ischemic stroke
and headache attributed to non-traumatic intracranial
hemorrhage) [12].
Statistical Analysis
Parametric and non-parametric tests were used to com-
pare demographic, clinical, and functional data for the
three subgroups (acute, subacute, and chronic stroke
stages). Binary data related to the presence of each
type of pain were reported as percentages and analyzed
with Pearson v2-test applied to a 32 cross table using
the stroke stage (acute, subacute, or chronic) as the
three-variant factor and the presence or not of that type
of pain as the binary factor. Pearson v2-test applied to
2 2 cross tables was then used for post hoc analysis
applying Bonferroni correction on the alpha-level.
Pearson v2-test was also applied in the frequency analy-
sis of NPSI items.
Forward binary linear regression was performed to iden-
tify the dichotomized factors associated to overall pain or
subtypes of pain. The investigated risk factors were: age
(<65 years or not), gender, type of stroke (hemorrhagic
vs ischemic), and severity of stroke (as assessed with
NIHSS in the acute stage and Barthel Index in subacute
and chronic stages). Odds ratio was computed as the
exponential of beta-coefficient of regressions. The 95%
confidence interval (CI95%) was computed as well.
Results
During the 2-year study, 485 eligible patients were iden-
tified in stroke units and neurological departments and
297 patients in rehabilitation units. Among the eligible
patients, 52 refused to be enrolled, 174 patients had
incomplete data, and 10 inconsistent data (Figure 1).
The data for 546 assessments were analyzed (these
data concerned 443 patients, 103 of whom were
assessed more than one time during the acute and sub-
acute or chronic stages). Demographic and clinical data
are reported in Table 1.
The mean prevalence of the various pain types studied
was 29.59%, but the percentage ranged widely in the
three stroke stages: 14.06% in the acute, 42.73% in the
subacute, and 31.90% in the chronic stage. Pain was
significantly associated with the stroke stage (P< 0.001,
Figure 2). Whereas prevalence of musculoskeletal pains,
shoulder pain, spasticity-related pain, and headache dif-
fered significantly across the three stroke stages
(P<0.05, Figure 2), CPSP prevalence, though higher in
the subacute and chronic stages than in the acute
stage, did not significantly differ across the three stages
(P ¼ 0.1).
The frequencies of the different types of pain, as
assessed with NPSI, did not significantly differ (they
ranged from 35% to 67%). All the different types of pain
had a median value of severity between 5 and 6 (except
pain evoked by cold stimuli), with a score ranging
between 2 and 7 (Table 2).
Post hoc analyses showed that pain overall, as well as
musculoskeletal pains and shoulder pain, had a higher
prevalence in the subacute and chronic stages than in
the acute stage (P< 0.001). Conversely, the prevalence
of spasticity-related pain was higher in the chronic than
in other stages (P< 0.001). Headache tended to
decrease without significant post hoc comparisons. In
97 out of 546 assessments (17.8%), patients com-
plained of more than one type of pain.
The time course of the different types of pain in the 103
patients assessed more than once was similar to that of
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the entire sample, except the spasticity-related pain
(Figure S1, Supplementary Data file). The frequency of
this type of pain was higher in the chronic stage than in
the other stroke stages; this difference nevertheless
failed to reach the statistical significance.
Table 3 reports the risk factors associated with overall
pain and the specific types of pain. Young patients
(<65 years) and women had a probability 1.7 times
higher to suffer from pain. Patients with hemorrhagic
stroke and women had a higher risk of suffering from
headache (P<0.05). Similar results were found in the
subgroup of patients in the acute stage (P< 0.05). In
the subacute stage, none of the investigated factors
were significantly associated with pain. In the chronic
stage we found a mild association between age lower
than 65 years and CPSP. We did not find any
association between pain and the severity of stroke, as
assessed with NIHSS in the acute stage, and Barthel
Index in the subacute and chronic stage.
In the acute stage only one patient with CPSP under-
went analgesic treatment with acetaminophen. In the
subacute and chronic phases, four of the 13 patients
with CPSP (30.8%) were treated: two patients with pre-
gabalin, one with gabapentin plus oxcarbazepine, and
one with non-steroidal anti-inflammatory drugs.
Discussion
Our repeated cross-sectional, hospital-based, multicen-
ter study, using bedside clinical examination and widely
agreed criteria for diagnosing post-stroke pains, pro-
vides reliable information confirming in a large
Table 1 Demographical and clinical features of patients (mean6 standard deviation are reported for age
and time from onset)
Feature\Phase Acute phase Subacute phase Chronic phase
N assessments 320 110 116
Age (years) 67.166 14.08 67.606 14.18 66.596 14.73
Time from stroke (days) 2.106 2.83 47.776 24.42 174.896 107.71
Gender 61.6% men 59.1% men 58.6% men
Type of stroke 92.8% ischemic 90.0% ischemic 87.9% ischemic
Side of hemiparesis/hemiplegia 53.1% right 61.8% right 49.6% right
46.9% left 38.2% left 50.4% left
Figure 2 Prevalence of post-stroke pain and the different pain types. Asterisks indicate a statistically significant dif-
ference among the different stroke stages (P< 0.05, by v2-test). CPSP¼ central post-stroke pain.
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population that pain is a common complication after
stroke. In the prospectively enrolled patients hospitalized
or attending Italian stroke units and stroke rehabilitation
divisions, it affected about 30% of stroke survivors, and
the prevalence peaked in the subacute stroke stage
(40% of patients).
The mean 30% prevalence of post-stroke pain in our
population is in line with several studies reporting a
prevalence ranging from 10% to 45.8% [1–3,13]. With
respect to previous studies mainly focused on one type
for pain investigated in a specific phase of stroke, our
study provides a new insight detailing a clear time
course for the different pain types, showing that the
prevalence of post-stroke pain differs strikingly across
the acute, subacute, and chronic stroke stages.
The CPSP mean prevalence we found in our hospital-
based study is lower than that reported in previous
epidemiological studies [3,13]. The contrasting results
presumably reflect the different methodological
approaches. Whereas we explicitly diagnosed CPSP
with clinical examination and validated questionnaires,
previous studies frequently assessed pain and neuro-
pathic pain by mail questionnaire alone. The DN4 ques-
tionnaire that we used in our study was specifically
designed to diagnose neuropathic pain, thus increasing
diagnostic specificity and reducing false-positive diagno-
ses, an especially important advantage in a condition
producing different types of pain, such as stroke. The
DN4 is a valid tool for screening patients with suspected
neuropathic pain and achieves high diagnostic specific-
ity and sensitivity (about 80%) [7]. In our study the
CPSP prevalence ranged between 2.5% and 6.4%
across the three post-stroke stages. Although the few
subjects with CPSP reduced test power, and thus pre-
vented a statistically significant difference in prevalence
across the three stroke stages, we identified a trend in
which CPSP prevalence seems to be higher in the sub-
acute and chronic stages than in the acute stage. The
fact that CPSP is more frequent in the subacute and
chronic stages is in line with previous studies showing
that neuropathic pain, probably owing to plastic
changes in the somatosensory and pain pathways, is a
delayed complication after stroke [14,15]. Our study
provides the previously unreported finding of NPSI anal-
ysis in patients with CPSP. The frequency and the
severity of the different types of pain did not differ.
However, given that only a few patients suffered from
CPSP, caution is needed in interpreting these results.
Further studies, collecting a large sample of patients with
CPSP, might reach more reliable conclusions on CPSP.
When we investigated the various nociceptive post-stroke
pains, we found that the most frequent pain type was
musculoskeletal pain (low back pain, joint pains). Its prev-
alence reached about 37% between the first and
second month after stroke, and then decreased to 28%.
This time course probably reflects the observation that





Q1: Burning 49.2 6 (4; 7)
Q2: Squeezing 44.3 5 (3; 7)
Q3: Pressure 46.4 5 (3; 7)
Q5: Electric shocks 49.2 5 (3; 7)
Q6: Stabbing 35.1 5 (2; 7)
Q8: Evoked by brushing 39.7 5 (3; 7)
Q9: Evoked by pressure 44.8 5 (2; 7)
Q10: Evoked by cold stimuli 30.1 4 (2; 6)
Q11: Pins and needles 55.9 5 (3; 7)
Q12: Tingling 66.8 6 (3; 7)
Q4 and Q7 not reported. They refer to the temporal sequence
of spontaneous ongoing pain (Q1/Q2/Q3) and paroxysmal
pain (Q5/Q6).
*Percentage of patients who reported a score>0.
†Median (first; third quartiles) values of patients who reported
a score>0.
Table 3 Risk factors for the different types of pain
Phase Type of pain Factor P OR (CI95%)
All patients Overall pain Female gender 0.007 1.735 (1.159–2.599)
Age<65 0.009 1.723 (1.159–2.588)
Headache Female gender 0.006 3.998 (1.498–10.671)
Hemorrhagic stroke 0.049 3.217 (1.003–10.314)
Acute Overall pain Female gender 0.006 2.518 (1.304–4.862)
Hemorrhagic stroke 0.035 3.027 (1.082–8.469)
Headache Female gender 0.015 3.774 (1.293–11.012)
Hemorrhagic stroke 0.036 4.500 (1.099–18.421)
Chronic CPSP Age<65 0.040 9.848 (1.105–87.781)
Data obtained with forward binary logistic regression (P value refers to the last value, OR is the odds ratio obtained as exponen-
tial of coefficient beta of regression, CI95% is the 95% confidence interval). No significant risk factor was identified in the suba-
cute phase.
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musculoskeletal disorders receive more adequate atten-
tion in rehabilitation wards than in stroke wards [16].
Our findings show that the prevalence of shoulder pain is
negligible in the acute stage, then markedly increases in
the subacute stage. In this later stage we found a preva-
lence of 18%, similar to that reported in a recent large
population-based study in patients at 1 month after
stroke [17,18]. The time course we found confirmed
shoulder pain as a typically delayed complication after
stroke. Although this time course might merely reflect
rotator cuff disorders, adhesive capsulitis, shoulder sub-
luxation and shoulder muscle spasticity, it indirectly
implies that this type of pain might depend partly on cen-
tral sensitization [19]. Accordingly, in our study the time
course of shoulder pain paralleled that for CPSP.
The prevalence of spasticity-related pain was higher in the
chronic than in the acute post-stroke stage. The patho-
physiological mechanism underlying this type of pain is
potentially multifactorial and strictly related to how stroke
units, rehabilitation centers, and caregivers at home man-
age secondary complications [20,21], including musculos-
keletal consequences related to abnormal postures (soft
tissue and joint stiffness; joint subluxations; and several
lower-limb sequelae, such as equinovarus, hyperextended
knee, and adducted hip) and secondary tissue damage
from abnormal postures, such as decubitus ulcers. The
increasing prevalence of pain related to spasticity in the
chronic stroke stage could therefore reflect poor attention
to correct positioning after discharge from the rehabilitation
hospital and poor compliance with specific drug treatment.
Our finding that headache complicates mainly the acute
stroke stage, agrees with previous studies [22]. The
prevalence rate we found is lower than that reported in
a previous large study including both hemorrhagic and
ischemic stroke (5% vs 18%) [23]. The contrasting
results might depend on the few patients with hemor-
rhagic stroke we enrolled. Accordingly, the headache
prevalence we found matches that from a previous
study collecting only patients with ischemic stroke [24].
Unexpectedly, only 30% of patients with CPSP in the
acute stroke stage and 11% in the subacute and chronic
stages underwent analgesic treatment. The reasons why
patients with post-stroke pain receive inadequate therapy
could be the difficulty in diagnosing the different pain
types related to stroke, the insufficient awareness about
CPSP, and the poor therapeutic options [25].
When we analyzed the risk factors, we found that age
and gender influenced post-stroke pain. Patients
younger than 65 years and women have a higher risk of
suffering from pain. Although these findings partly argue
against earlier observation, they are in line with a recent
study reporting a significant association between gen-
der, age, and post-stroke pain [26]. We have also found
that patients with hemorrhagic stroke had a higher risk
of headache. This association is probably due to local
distention, distortion, deformation, or stretching of pain-
sensitive intracranial structures [27]. In our study women
had an higher risk of suffering from stroke-associated
headache. This finding probably suggests that besides
the well-known higher incidence of migraine and tension
type headache in women, gender might also influence
symptomatic headaches.
Our study showing that the prevalence of stroke-related
pain is higher in the subacute and chronic stages than
in the acute stage and that each type of pain follows a
distinct time course should help neurologists managing
this common post-stroke complication so that their
patients benefit from a better quality of life.
Supplementary Data
Supplementary Data are available online at http://
www.painmedicine.oxfordjournals.org.
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